MerrillA.BielMDPhD FACS

Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery, Laryngology & Voice Disorders

Professor, Otolaryngology, University of Minnesota Medical School

Dr. Biel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2211 Park Ave
Minneapolis, MN 55404
Phone+1 612-871-1144

Fax+1 612-871-2012

University of MinnesotaResidency, Otolaryngology - Head and Neck Surgery, 1983 - 1987
Hennepin HealthcareResidency, Surgery, 1982 - 1983
University of MinnesotaInternship, Internal Medicine, 1981 - 1982
University of Illinois College of MedicineClass of 1981

PubMed

6 citations
Effects of methylene blue photodynamic therapy on oral carcinoma and leukoplakia cells.
Mina N Le, Beverly R Wuertz, Merrill A Biel, Rachel L Thompson, Frank G Ondrey
Laryngoscope Investigative Otolaryngology. 2022-08-01
68 citations
Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
David Cognetti, Jennifer Johnson, Joseph Curry, Samith T. Kochuparambil, Darren McDonald
Head & Neck. 2021-10-09
48 citations
A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma
Makoto Tahara, Susumu Okano, Tomohiro Enokida, Yuri Ueda, Takao Fujisawa
International Journal of Clinical Oncology. 2021-06-24

Lectures

A global phase III multicenter, randomized, double-arm, open label trial of ASP-1929 photoimmunotherapy versus physician’s choice standard of care for the treatment of...
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Rakuten Aspyrian Enrolling Phase 3 Trial of ASP-1929 for Head and Neck CancerDecember 17th, 2018
Aspyrian Therapeutics Inc. Announces Successful Advances in RM-1929 Clinical Development in Recurrent Head and Neck Cancer, Including Fast Track Designation Granted by the FDA, Initiation of Clinical Studies in Japan, and Plans to Start Pivotal Studies, WJanuary 16th, 2018

Photodynamic Treatment Of Endotracheal Tube BiofilmsNational Institute Of Allergy And Infectious Diseases2005–2007
Antimicrobial Chronic Wound Bandage TreatmentNational Institute Of Nursing Research2004–2006
Treatment Of Aids-Related Oral CandidiasisNational Institute Of Dental &Craniofacial Research2002–2004
Phototherapy Of Antibiotic Resistant Wound InfectionsNational Institute Of Allergy And Infectious Diseases2000